Literature DB >> 1737933

HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha 1-helix.

W H Hildebrand1, J A Madrigal, A M Little, P Parham.   

Abstract

Various HLA-B molecules exhibit serologic cross-reactions with HLA-B7, including HLA-B27, B40, Bw42, and Bw22. Of this group, primary structures for the three serologic subdivisions of HLA-Bw22, HLA-Bw54, Bw55, and Bw56, have yet to be determined. Here, we describe the nucleotide sequences of five distinctive HLA-Bw22 alleles isolated from cells of different ethnic origins typed either for Bw54, Bw55, or Bw56. Heterogeneity in molecules typed as Bw55 and Bw56 was defined. The five HLA-Bw22 alleles form a closely related family that appears to have evolved by a series of simple gene conversion events, all of which alter the antigen recognition site of the encoded proteins. Of note, HLA-Bw54 is the product of a gene conversion between HLA-B and C alleles. All the Bw22 alleles encode an alpha 1-helix identical in amino acid sequence to that of HLA-B7 and Bw42, a feature almost certainly responsible for the serologic cross-reactivity of these molecules. Shared substitutions in the alpha 1-helix can also explain the cross-reactivity of Bw22 and B7 with B27. Patterns of amino acid substitution in the alpha 2-domain of Bw22 heavy chains correlate with certain antibody and T cell cross-reactivities, thereby implicating particular amino acids in their target epitopes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737933

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  MHC class I genes in the owl monkey: mosaic organisation, convergence and loci diversity.

Authors:  Paula P Cardenas; Carlos F Suarez; Pilar Martinez; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  Immunogenetics       Date:  2005-01-15       Impact factor: 2.846

2.  Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  A novel method for simultaneous high resolution identification of HLA-A, HLA-B, and HLA-Cw alleles.

Authors:  R Arguello; H Avakian; J M Goldman; J A Madrigal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

4.  A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.

Authors:  M Fennessy; K Metcalfe; G A Hitman; M Niven; P A Biro; J Tuomilehto; E Tuomilehto-Wolf
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

5.  Two subtypes of HLA-B51 differing by substitution at position 171 of the alpha 2 helix.

Authors:  G Kawaguchi; W H Hildebrand; M Hiraiwa; S Karaki; T Nagao; N Akiyama; H Uchida; K Kashiwase; T Akaza; R C Williams
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.

Authors:  J Zemmour; P Parham
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

Review 7.  Association of HLA class I and II genes with cutaneous leishmaniasis: a case control study from Sri Lanka and a systematic review.

Authors:  Nilakshi Samaranayake; Sumadhya D Fernando; Nilaksha F Neththikumara; Chaturaka Rodrigo; Nadira D Karunaweera; Vajira H W Dissanayake
Journal:  BMC Infect Dis       Date:  2016-06-14       Impact factor: 3.090

8.  The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands.

Authors:  Hugo G Hilton; Curtis P McMurtrey; Alex S Han; Zakia Djaoud; Lisbeth A Guethlein; Jeroen H Blokhuis; Jason L Pugh; Ana Goyos; Amir Horowitz; Rico Buchli; Ken W Jackson; Wilfred Bardet; David A Bushnell; Philip J Robinson; Juan L Mendoza; Michael E Birnbaum; Morten Nielsen; K Christopher Garcia; William H Hildebrand; Peter Parham
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.